Intensity Therapeutics, Inc. granted 180-day extension by Nasdaq to meet bid price requirement. Nasdaq symbol: INTS.

Unusual Whales
2025.12.05 12:33
On December 5, 2025, in Shelton, Connecticut, Intensity Therapeutics, Inc. (Nasdaq: INTS), a prominent late-stage clinical biotechnology firm, announced its dedication to discovering and developing innovative intratumoral cancer treatments. The company is focused on creating therapies that can effectively eradicate tumors.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer